Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/2003
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307471A1 16alpha-methyl or ethyl substituted estrogens
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1135154B1 Improvement of folliculogenesis
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1049460B1 Method for the prophylactic treatment of mastitis
05/07/2003EP0971722B1 An aphrodisiac for application to the sexual organs
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415603A Salt of leonurine and its preparation
05/07/2003CN1415371A Medicament for curing colpitis mycotica and trichomonal vaginitis and its preparation method
05/07/2003CN1415363A Biochemical medicament of araliaceae plant and its preparation method
05/07/2003CN1415355A Method for preparing capsule of snail powder
05/07/2003CN1415346A Oral liquid for nephrosis
05/07/2003CN1415334A Preparation of papaya for human and livestock to increase milk and its prepn. process
05/07/2003CN1415307A ÔÇÿXiao BilingÔÇÖ pessary
05/07/2003CN1107517C Antiabortifacient for treating acyesis and sterility and its preparing process
05/07/2003CN1107516C Antiabortifacient for treating male endocrine Sterility and its preparing process
05/07/2003CN1107515C Prepn. of external-applied medicine for mastoproliferation
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559282 Induction of antibodies against leutenizing hormone releasing hormone in mammals; obtain mammal, administer modulator, monitor immune response, evaluate for prevention of infections
05/06/2003US6559184 Methods and compositions for treating male erectile dysfunction
05/06/2003US6559153 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders
05/06/2003CA2121674C Biocompatible implant for the timing of ovulation in mares
05/02/2003EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
05/02/2003EP1306087A1 Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305635A2 Methods to identify compounds that modulate rage
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305314A1 Crystalline therapeutic agent
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE
05/02/2003EP1305300A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305027A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/02/2003EP1305024A1 Method for treating fibrotic diseases or other indications ic
05/02/2003EP1305023A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis
05/02/2003EP1305015A1 Substituted styryl benzylsulfones for treating proliferative disorders
05/02/2003EP1305014A1 Method for the treatment of climacteric disorders in women during or after the menopause
05/02/2003EP1305004A1 Embolization using carbon coated particles
05/02/2003EP1121375B1 High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
05/02/2003EP1093361B1 Plaster which contains steroids, and a method for the production and use thereof
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035686A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035653A1 Pyridothienopyrimidine compound and salt thereof
05/01/2003WO2003035650A1 Entry inhibitor
05/01/2003WO2003035646A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035622A1 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/01/2003WO2003035102A1 Use of egf to inhibit pathogenic infections of the urogenital tract
05/01/2003WO2003035072A1 Use of flibanserin in the treatment of sexual disorders
05/01/2003WO2003035069A1 Apomorphine-containing dosage form for ameliorating male erectile dysfunction
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035059A2 Spermicides
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003035005A2 Heteroindanes: a new class of potent cannabimimetic ligands
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003005989A3 Granulates containing liposoluble substances and a process for the preparation thereof
05/01/2003WO2002100351A3 A method for treating inflammatory diseases by administering a ppar-delta agonist
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002060458A3 Compositions and method of tissue superoxygenation
05/01/2003WO2002005830A3 Extracts from crassulacean acid metabolism (cam) mechanism plants and uses thereof
05/01/2003US20030083610 Compositions and method of tissue superoxygenation
05/01/2003US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
05/01/2003US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole
05/01/2003US20030083344 Tryptase inhibitors
05/01/2003US20030083337 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083228 Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction
05/01/2003US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082227 Drug delivery; multilayer reservoir
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2464609A1 Use of egf to inhibit pathogenic infections of the urogenital tract
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003CA2464368A1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 557